Reported about 15 hours ago
President Trump announced an executive order aimed at reducing drug prices in the U.S. by eliminating pharmacy benefit managers (PBMs) from the pricing process. This move seeks to align U.S. drug prices with those in Europe, prompting a decline in PBM stocks while pharmaceutical shares rose. Trump emphasized direct sales from manufacturers to consumers to combat high drug costs, which are significantly higher in the U.S. compared to other countries.
Source: YAHOO